Court Allows Government to Proceed with Case Alleging that Teva Conspired with Two Foundations to Pay Kickbacks to Copaxone Patients

On September 9, 2021, a judge in the United States District Court for the District of Massachusetts denied Teva Pharmaceuticals' motion to dismiss the United States' complaint alleging that Teva paid hundreds of millions of dollars in kickbacks to Copaxone patients via two foundations, Chronic Disease Fund dba Good Days (CDF)...

Continue reading…

South Carolina Healthcare Orgs ordered to pay $140 million to settle Uncontested FCA whistleblower charges

A group of South Carolina healthcare providers, laboratories, and testing facilities owned or managed by chiropractor Daniel McCollum will pay a total of $140 million to the U.S. government after failing to defend against charges of kickback schemes and unnecessary testing brought forth by a whistleblower complaint. According to the U.S. Department...

Continue reading…

United States Indicts Spinal Device Company and Two of Its Executives for Paying Kickbacks to Spine Surgeons

On September 7, 2021, the U.S. Attorney's Office in Boston announced a grand jury indictment of medical device company SpineFrontier, Inc., and two of its executives, Kingsley Chin and Aditya Humad, for violating the anti-kickback statute by allegedly paying surgeons bogus "consulting" fees to induce the surgeons to use SpineFrontier products...

Continue reading…

U.S. files suit against Univ of Pittsburgh Med Center and Dept Chair for performing as many as three complex surgeries at the same time

The U.S. Government has filed a lawsuit against the University of Pittsburgh Medical Center and James Luketich, M.D. Chair of UPMC's Department of Cardiothoracic Surgery. The complaint alleges that Dr. Luketich regularly performs as many as three, complex surgical procedures at the same time, fails to participate in...

Continue reading…

Appeals Court Affirms All Convictions of Insys Executives

Today, the First Circuit affirmed all of the convictions of the executives of Insys, the manufacturer of a highly-addictive sublingual fentanyl spray that the FDA had approved only to treat breakthrough cancer pain. Congratulations to Assistant United States Attorneys Nat Yeager and David Lazarus for successfully leading perhaps the most important pharma...

Continue reading…

Calif. Attorney General Settles case against Bristol Meyers for $75 Million for claims it underpaid drug rebates it owed to state Medicaid program

California Attorney General Rob Bonta today announced a $75 million nationwide settlement with global pharmaceutical company Bristol Myers Squibb (BMS), resolving allegations that BMS underpaid the drug rebates owed to Medi-Cal and other state Medicaid programs. According to a complaint filed by a whistleblower, BMS overcharged the states for its pharmaceuticals by...

Continue reading…